GNH USA

Europe — EMA

Octaplas (Human Plasma Protein)

Human Plasma Protein, the active ingredient in Octaplas, is a plasma-derived protein therapy presented as a sterile liquid for intravenous use.

Request sourcing

1
Pack/s

What is Human Plasma Protein?

Human Plasma Protein, the active ingredient in Octaplas, is a plasma-derived protein therapy presented as a sterile liquid for intravenous use. It is used to support hemostasis in patients with complex coagulation needs, such as those undergoing major surgery or experiencing massive bleeding.

GNH USA supplies Octaplas as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals and transplant centres worldwide.

What is Human Plasma Protein used for?

Octaplas is a plasma‑derived therapy that addresses hemostatic challenges across several clinical contexts. - Major surgical bleeding: Helps to restore hemostasis during high‑risk procedures. - Trauma‑induced hemorrhage: Contributes to rapid coagulation restoration in traumatic injury. - Liver transplantation and hepatic resection procedies :           i ​   t  

What precautions apply to Human Plasma Protein?

{}

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Human Plasma Protein
Route
Intravenous Use
Manufacturer
Octapharma Pharmazeutika Produktionsgesmbh
Origin
EU

Related products